Titre : | Drug Testing and Analysis, Vol.11, n°8 - August 2019 |
Type de document : | Bulletin : Périodique |
Paru le : | 01/08/2019 |
Année de publication : | 2019 |
Format : | 1117-1276 |
Langues: | Anglais |
Discipline : | PRO (Produits, mode d'action, méthode de dépistage / Substances, action mode, screening methods) |
Note de contenu : |
SELECTION :
- In vitro metabolism of the novel synthetic opioid agonist cyclopropylfentanyl and subsequent confirmation in authentic human samples using liquid chromatography-high resolution mass spectrometry. Cutler C., Hudson S., p. 1134-1143. - Syntheses and analytical characterizations of the research chemical 1-[1-(2-fluorophenyl)-2-phenylethyl]pyrrolidine (fluorolintane) and five of its isomers. Dybek M., Wallach J., Kavanagh P.V., Colestock T., Filemban N., Dowling G., et al., p. 1144-1161. - Simultaneous quantification of ten key Kratom alkaloids in Mitragyna speciosa leaf extracts and commercial products by ultra-performance liquid chromatography-tandem mass spectrometry. Sharma A., Kamble S.H., Leon F., Chear N.J.-Y., King T.I., Berthold E.C., et al., p. 1162-1171. - Variability in content and dissolution profiles of MDMA tablets collected in the UK between 2001 and 2018 - A potential risk to users? Couchman L., Frinculescu A., Sobreira C., Shine T., Ramsey J., Hecht M., et al., p. 1172-1182. - Chemical profiling of the synthetic cannabinoid MDMB-CHMICA: Identification, assessment, and stability study of synthesis-related impurities in seized and synthesized samples. Münster-Müller S., Hansen S., Opatz T., Zimmermann R., Pütz M., p. 1192-1206. - In vitro Phase I metabolism of indazole carboxamide synthetic cannabinoid MDMB-CHMINACA via human liver microsome incubation and high-resolution mass spectrometry. Presley B.C., Logan B.K., Jansen-Varnum S.A., p. 1264-1276. |
Cote : | Abonnement |
Lien : | https://onlinelibrary.wiley.com/toc/19427611/2019/11/8 |
Exemplaires
Disponibilité |
---|
aucun exemplaire |
Accueil